BioGenCell Europe SA SA
BioGenCell Europe SA reported total assets of 386,698 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Mar 2026).
The score of BioGenCell Europe SA shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -28 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BioGenCell Europe SA's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 26 Mar 2026
- Year ended 30 Sep 2024filed on 28 Mar 2025
- Year ended 30 Sep 2023filed on 29 Mar 2024
- Year ended 30 Sep 2022filed on 21 Mar 2023
- Year ended 30 Sep 2021filed on 29 Mar 2022
BioGenCell Europe SA's financial analysis
- Solvency15.8%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BioGenCell Europe SA
BioGenCell Europe SA's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0678.674.356
- VAT number
- BE0678674356
- Peppol
- Registered · 0208:0678674356 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 18 Jul 2017
- Registered office
- 1410 Waterloo
- Latest accounts
- 2025 · filed on 26 Mar 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
BioGenCell Europe SA (SA) has been based in Waterloo since 2017, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net loss of 8,922 € and equity of 61,045 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to BioGenCell Europe SA
Companies in the same business, of comparable size and area, outside its group.
- MSI-Dfat EU Research and experimental development on natural sciences and engineering Jodoigne · balance sheet €1.08m
- Ryp Labs Research and experimental development on natural sciences and engineering Machelen (Brab.) · balance sheet 387,284 €
- Polygest Research and experimental development on natural sciences and engineering Pont-à-Celles · balance sheet 380,465 €
- Research Link Research and experimental development on natural sciences and engineering Thuin · balance sheet 477,442 €
- Klinifarm Research and experimental development on natural sciences and engineering Hasselt · balance sheet 487,335 €
- Precision for Medicine (BEL) Research and experimental development on natural sciences and engineering Saint-Josse-ten-Noode · balance sheet 301,997 €
- Calidris Bio Research and experimental development on natural sciences and engineering Antwerp · balance sheet 506,792 €
- HORPI Systems Research and experimental development on natural sciences and engineering Visé · balance sheet 572,679 €
Frequently asked questions about BioGenCell Europe SA
What is the revenue of BioGenCell Europe SA?
BioGenCell Europe SA files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of BioGenCell Europe SA?
In Belgium, the VAT number is the company number prefixed with BE: BE0678674356 for BioGenCell Europe SA, if the company is VAT-registered. Its company number (CBE) is 0678.674.356.
Where is the registered office of BioGenCell Europe SA?
According to the CBE register, the registered office of BioGenCell Europe SA is in 1410 Waterloo.
What is the equity of BioGenCell Europe SA?
At the close of the 2025 financial year, the equity of BioGenCell Europe SA amounts to 61,045 €, a solvency of 15.8% of total assets.
Who manages BioGenCell Europe SA?
The register lists 3 active mandates at BioGenCell Europe SA. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of BioGenCell Europe SA
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →